These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

666 related articles for article (PubMed ID: 12663930)

  • 1. Detection of amyloid plaques by radioligands for Abeta40 and Abeta42: potential imaging agents in Alzheimer's patients.
    Kung MP; Skovronsky DM; Hou C; Zhuang ZP; Gur TL; Zhang B; Trojanowski JQ; Lee VM; Kung HF
    J Mol Neurosci; 2003 Feb; 20(1):15-24. PubMed ID: 12663930
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amyloid binding ligands as Alzheimer's disease therapies.
    Lee VM
    Neurobiol Aging; 2002; 23(6):1039-42. PubMed ID: 12470800
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Styrylbenzoxazole derivatives for in vivo imaging of amyloid plaques in the brain.
    Okamura N; Suemoto T; Shimadzu H; Suzuki M; Shiomitsu T; Akatsu H; Yamamoto T; Staufenbiel M; Yanai K; Arai H; Sasaki H; Kudo Y; Sawada T
    J Neurosci; 2004 Mar; 24(10):2535-41. PubMed ID: 15014129
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radioiodinated styrylbenzene derivatives as potential SPECT imaging agents for amyloid plaque detection in Alzheimer's disease.
    Kung MP; Hou C; Zhuang ZP; Skovronsky DM; Zhang B; Gur TL; Trojanowski JQ; Lee VM; Kung HF
    J Mol Neurosci; 2002; 19(1-2):7-10. PubMed ID: 12212796
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Curcumin inhibits formation of amyloid beta oligomers and fibrils, binds plaques, and reduces amyloid in vivo.
    Yang F; Lim GP; Begum AN; Ubeda OJ; Simmons MR; Ambegaokar SS; Chen PP; Kayed R; Glabe CG; Frautschy SA; Cole GM
    J Biol Chem; 2005 Feb; 280(7):5892-901. PubMed ID: 15590663
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radioiodinated styrylbenzenes and thioflavins as probes for amyloid aggregates.
    Zhuang ZP; Kung MP; Hou C; Skovronsky DM; Gur TL; Plössl K; Trojanowski JQ; Lee VM; Kung HF
    J Med Chem; 2001 Jun; 44(12):1905-14. PubMed ID: 11384236
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of novel 123I-labeled pyridyl benzofuran derivatives for SPECT imaging of β-amyloid plaques in Alzheimer's disease.
    Ono M; Cheng Y; Kimura H; Watanabe H; Matsumura K; Yoshimura M; Iikuni S; Okamoto Y; Ihara M; Takahashi R; Saji H
    PLoS One; 2013; 8(9):e74104. PubMed ID: 24058519
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Binding characteristics of radiofluorinated 6-dialkylamino-2-naphthylethylidene derivatives as positron emission tomography imaging probes for beta-amyloid plaques in Alzheimer's disease.
    Agdeppa ED; Kepe V; Liu J; Flores-Torres S; Satyamurthy N; Petric A; Cole GM; Small GW; Huang SC; Barrio JR
    J Neurosci; 2001 Dec; 21(24):RC189. PubMed ID: 11734604
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Post-mortem correlates of in vivo PiB-PET amyloid imaging in a typical case of Alzheimer's disease.
    Ikonomovic MD; Klunk WE; Abrahamson EE; Mathis CA; Price JC; Tsopelas ND; Lopresti BJ; Ziolko S; Bi W; Paljug WR; Debnath ML; Hope CE; Isanski BA; Hamilton RL; DeKosky ST
    Brain; 2008 Jun; 131(Pt 6):1630-45. PubMed ID: 18339640
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characteristics of aquaporin expression surrounding senile plaques and cerebral amyloid angiopathy in Alzheimer disease.
    Hoshi A; Yamamoto T; Shimizu K; Ugawa Y; Nishizawa M; Takahashi H; Kakita A
    J Neuropathol Exp Neurol; 2012 Aug; 71(8):750-9. PubMed ID: 22805778
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of IMPY as a potential imaging agent for beta-amyloid plaques in double transgenic PSAPP mice.
    Kung MP; Hou C; Zhuang ZP; Cross AJ; Maier DL; Kung HF
    Eur J Nucl Med Mol Imaging; 2004 Aug; 31(8):1136-45. PubMed ID: 15007564
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Iron treatment inhibits Aβ42 deposition in vivo and reduces Aβ42/Aβ40 ratio.
    Shen X; Liu J; Fujita Y; Liu S; Maeda T; Kikuchi K; Obara T; Takebe A; Sayama R; Takahashi T; Matsue A; Sera K; Michikawa M; Komano H; Zou K
    Biochem Biophys Res Commun; 2019 May; 512(4):653-658. PubMed ID: 30791980
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of radioiodinated ligand binding to amyloid beta plaques.
    Kung MP; Zhuang ZP; Hou C; Jin LW; Kung HF
    J Mol Neurosci; 2003; 20(3):249-54. PubMed ID: 14501004
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antemortem-Postmortem Correlation of Florbetapir (18F) PET Amyloid Imaging with Quantitative Biochemical Measures of Aβ42 but not Aβ40.
    Beach TG; Maarouf CL; Intorcia A; Sue LI; Serrano GE; Lu M; Joshi A; Pontecorvo MJ; Roher AE
    J Alzheimers Dis; 2018; 61(4):1509-1516. PubMed ID: 29376867
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [(11)C]PIB-amyloid binding and levels of Abeta40 and Abeta42 in postmortem brain tissue from Alzheimer patients.
    Svedberg MM; Hall H; Hellström-Lindahl E; Estrada S; Guan Z; Nordberg A; Långström B
    Neurochem Int; 2009; 54(5-6):347-57. PubMed ID: 19162107
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo SPECT imaging of amyloid-β deposition with radioiodinated imidazo[1,2-a]pyridine derivative DRM106 in a mouse model of Alzheimer's disease.
    Chen CJ; Bando K; Ashino H; Taguchi K; Shiraishi H; Shima K; Fujimoto O; Kitamura C; Matsushima S; Uchida K; Nakahara Y; Kasahara H; Minamizawa T; Jiang C; Zhang MR; Ono M; Tokunaga M; Suhara T; Higuchi M; Yamada K; Ji B
    J Nucl Med; 2015 Jan; 56(1):120-6. PubMed ID: 25476539
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Soluble amyloid beta peptide concentration as a predictor of synaptic change in Alzheimer's disease.
    Lue LF; Kuo YM; Roher AE; Brachova L; Shen Y; Sue L; Beach T; Kurth JH; Rydel RE; Rogers J
    Am J Pathol; 1999 Sep; 155(3):853-62. PubMed ID: 10487842
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular targeting of Alzheimer's amyloid plaques for contrast-enhanced magnetic resonance imaging.
    Poduslo JF; Wengenack TM; Curran GL; Wisniewski T; Sigurdsson EM; Macura SI; Borowski BJ; Jack CR
    Neurobiol Dis; 2002 Nov; 11(2):315-29. PubMed ID: 12505424
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and evaluation of 1-(4-[¹⁸F]fluoroethyl)-7-(4'-methyl)curcumin with improved brain permeability for β-amyloid plaque imaging.
    Lee I; Yang J; Lee JH; Choe YS
    Bioorg Med Chem Lett; 2011 Oct; 21(19):5765-9. PubMed ID: 21885280
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo detection of amyloid β deposition using ¹⁹F magnetic resonance imaging with a ¹⁹F-containing curcumin derivative in a mouse model of Alzheimer's disease.
    Yanagisawa D; Amatsubo T; Morikawa S; Taguchi H; Urushitani M; Shirai N; Hirao K; Shiino A; Inubushi T; Tooyama I
    Neuroscience; 2011 Jun; 184():120-7. PubMed ID: 21497641
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.